Join Now

Recent BioUtah News & Events

Everything Happening in Utah Life Sciences

May 28, 2026
BioUtah News
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)

New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence

May 28, 2026
BioUtah News
Co-Diagnostics Advances Ebola PCR Assay Development Strategy with Joint Venture CoSara

Joint development strategy has been developed to address international deployment requirements if current outbreak continues or expands globally

May 28, 2026
BioUtah News
NanoKar Therapeutics Announces Formal Appointment of Craig Mosman as Chief Executive Officer

Mosman to lead NanoKar’s next phase of translational validation, partner readiness, and strategic collaboration for its ITAM optimization platform

May 21, 2026
BioUtah News
Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards

Recognition places Lumea among elite global winners including Medtronic and Thermo Fisher Scientific in one of digital health’s most competitive annual programs

May 21, 2026
BioUtah News
Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert

Recent pathogens illustrate need for improved situational awareness capabilities, such as those provided by the Co-Dx PCR point-of-care platform

May 21, 2026
BioUtah News
BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System

Funds will fuel sales team expansion and broader market access, advancing the company’s leadership in Implantable Tibial Neuromodulation (ITNM) for the treatment of urgency urinary incontinence (UUI)

May 21, 2026
BioUtah News
PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress

351-patient trial completion marks a key milestone for the Celeste® program; topline data to be presented May 26 in Phoenix

May 7, 2026
BioUtah News
AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS

FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway” for CNM-Au8 based on neurofilament light (NfL) biomarker data

May 7, 2026
BioUtah News
BioMarin Presents New Data on the Effect of Long-Term Treatment with VOXZOGO® (vosoritide) on Arm Span, Bone Health and Growth in Children With Achondroplasia at the Pediatric Endocrine Society’s 2026 Annual Meeting

VOXZOGO is the only approved treatment for children with achondroplasia starting at birth, with over 10 years of clinical research demonstrating the long-term benefit on complications associated with achondroplasia

April 30, 2026
BioUtah News
Two ARUP Medical Directors Receive Career Achievement Awards

Two ARUP Medical Directors Receive Career Achievement Awards

April 30, 2026
BioUtah News
Canary Speech Introduces Free Voice-Based Check-In for Consumers to Help Identify Early Signs of Mental Health Decline

As gaps in early detection persist, a 45-second voice analysis offers a new way to identify signals of stress, anxiety, and depression during Mental Health Awareness Month

April 23, 2026
BioUtah News Funding
What to Know About the Reauthorized SBIR/STTR Grant Programs

What to Know About the Reauthorized SBIR/STTR Grant Programs

April 23, 2026
BioUtah News
H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity

H.C. Wainwright Initiates Coverage on SINTX Technologies with Buy Rating, Highlighting Silicon Nitride Platform Opportunity

April 23, 2026
BioUtah News
Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026

Calycia Bioscience Wins People’s Choice Award at Altitude Lab Demo Day 2026

April 23, 2026
BioUtah News
Freyya Wins San Antonio TechFuel 2026 Competition

Freyya Wins San Antonio TechFuel 2026 Competition

April 16, 2026
Policy News
UNIVERSITY OF UTAH HEALTH DEDICATES JAMES LEVOY SORENSON CENTER FOR MEDICAL INNOVATION

Apr 14, 2026 University of Utah Health dedicated the James LeVoy Sorenson Center for Medical Innovation, a $50-million world-class hub designed to accelerate transformative research, medical device development, and life science training. Made possible by a generous $22 million lead gift from the Sorenson Legacy Foundation, the state-of-the-art facility serves as the new heart of […]

April 16, 2026
BioUtah News
James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting

James LeVoy Sorenson Center for Medical Innovation Grand Opening, Ribbon Cutting

April 16, 2026
BioUtah News
PhotoPharmics Phase 2 Parkinson’s Disease

PhotoPharmics will be attending the American Academy of Neurology Annual Meeting (AAN) in Chicago, April 18-22.

April 16, 2026
BioUtah News
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan

April 9, 2026
BioUtah News
Freyya Selected as Finalist for Tech Fuel 2026

Freyya Selected as Finalist for Tech Fuel 2026

April 9, 2026
BioUtah News
The “White Glove” Delivery: How a Joke Landed Me in Iceland

The “White Glove” Delivery: How a Joke Landed Me in Iceland

April 9, 2026
BioUtah News
Owlet Dream Duo™ 3 Named ‘Best for Monitoring Baby’s Health’ in PARENTS 2026 Best for Baby Awards

The Only Pediatric Health Platform Pairing an FDA-Cleared Infant Wearable with a Cybersecurity-Certified Video Monitor Earns Top Recognition from Editors and Expert Testers

April 9, 2026
BioUtah News
Kimbell & Associates: Highlights of President Trump’s FY 2027 Budget Request

Kimbell & Associates offers highlights of President Trump’s FY 2027 Budget Request

April 2, 2026
BioUtah News
Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share

By Henry O’Connell, Canary Speech Five years into caring for a patient, a primary care physician saw her again shortly after she delivered her first child. The visit was scheduled as a routine six-week newborn evaluation. As is common in primary care, the encounter extended beyond the infant to include the mother’s well-being. During the […]

April 2, 2026
BioUtah News
University of Utah Earns Dual Recognition in Global and U.S. Patent Rankings

Author: Amanda Ashley, Director of Communications for Research & Innovation, Office of the Vice President for Research The University of Utah has been named to the National Academy of Inventors’ (NAI) 2025 Top 100 U.S. Universities Granted U.S. Utility Patents list, further reinforcing its position as a national leader in research, innovation, and commercialization. This […]

April 2, 2026
BioUtah News
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection […]

April 2, 2026
BioUtah News
CancerVax Reports Successful Initial Mouse Study with Breakthrough Results

First biodistribution study of the Company’s novel targeted lipid nanoparticle achieved systemic circulation with the potential to target many types of cancer Lehi, Utah, March 31, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that the initial biodistribution study […]

April 2, 2026
BioUtah News
TWO YEAR DATA ON EDWARDS LIFESCIENCES’ EVOQUE SYSTEM CONTINUE TO DEMONSTRATE SIGNIFICANT AND SUSTAINED PATIENT BENEFITS

TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient crossover NEW ORLEANS–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annual Scientific Session (ACC.26), demonstrating significant and sustained patient benefits […]

April 2, 2026
BioUtah News
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Via OrthoSpineNews   Major clinical milestone marks SINTX’s entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform SALT LAKE CITY, Utah, March 19, 2026 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramic biomaterials and silicon nitride medical device innovation, […]

April 2, 2026
BioUtah News
Co-Diagnostics Joint Venture CoMira Receives Approval for Manufacturing Facility in Kingdom of Saudi Arabia’s Sudair Industrial City

Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi Arabia SALT LAKE CITY, April 2, 2026 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or “the Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoMira […]

April 2, 2026
BioUtah News
Nelson Labs® Offers Rare Inside Look at Lab Expansion Designed to Help Protect Patient Safety

Salt Lake City–based laboratory opens normally restricted space to invited guests, highlighting the behind‑the‑scenes work that helps keep medicines and medical products safe   SALT LAKE CITY (April 1, 2026) — Nelson Labs, a Salt Lake City–founded global leader in laboratory testing services, recently hosted invited guests for a rare look inside a new cleanroom […]

April 1, 2026
BioUtah News
Fluidx Medical Announces First Patient Treated with Novel Embolic Gel

Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient.